Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionKeel Point, LLC
Latest Disclosed Ownership7,738 shares
Latest Disclosed Value $ 469,336
Keel Point, LLC reports 23.82% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 29, 2026 - Keel Point, LLC filed a 13F-HR form disclosing ownership of 7,738 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $405,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 10,158 shares of Bristol-Myers Squibb Company. This represents a change in shares of -23.82% during the quarter. The current value of the position is $367,052 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 7,738 -2,420 -23.82 469 -14.26 0.0304
2026-02-12 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,158 2,104 26.12 548 50.69 0.0330
2025-12-16 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,054 728 9.94 363 7.08 0.0223
2025-08-15 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,326 526 7.74 339 -18.12 0.0224
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,800 1,152 20.40 415 29.78 0.0322
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,648 642 12.82 319 23.17 0.0256
2024-11-14 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,006 104 2.12 259 7.92 0.0216
2024-08-14 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,902 575 13.29 240 2.56 0.0217
2024-04-16 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,327 4,327 235 0.0243
2024-01-30 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -3,972 -100.00 0 -100.00
2023-10-26 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,972 -347 -8.03 231 -16.67 0.0316
2023-07-12 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,319 851 24.54 276 15.00 0.0369
2023-04-03 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,468 -104 -2.91 240 -6.61 0.0347
2023-01-17 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,572 743 26.26 257 27.86 0.0403
2022-10-05 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,829 23 0.82 201 -4.29 0.0345
2022-08-11 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,806 -263 -8.57 210 -6.25 0.0327
2022-04-27 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 3,069 3,069 224 0.0336
2021-11-04 2021-09-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 0 -258 -100.00 0 -100.00
2021-08-06 2021-06-30 13F BRISTOL-MYERS SQUIBB CO COM COM 110122108 258 258 558 0.1315
2019-05-14 2019-03-31 13F Bristol Myers Squibb COM 110122108 0 -6,355 -100.00 0 -100.00
2019-02-08 2018-12-31 13F Bristol Myers Squibb COM 110122108 6,355 -450 -6.61 330 -21.80 0.0447
2018-11-07 2018-09-30 13F Bristol Myers Squibb COM 110122108 6,805 480 7.59 422 20.57 0.0524
2018-08-13 2018-06-30 13F Bristol Myers Squibb COM 110122108 6,325 0 0.00 350 -12.50 0.0466
2018-05-07 2018-03-31 13F Bristol Myers Squibb COM 110122108 6,325 0 0.00 400 3.09 0.0547
2018-02-08 2017-12-31 13F Bristol Myers Squibb COM 110122108 6,325 0 0.00 388 -3.72 0.0537
2017-11-09 2017-09-30 13F Bristol Myers Squibb COM 110122108 6,325 0 0.00 403 14.49 0.0614
2017-08-15 2017-06-30 13F Bristol Myers Squibb COM 110122108 6,325 39 0.62 352 2.92 0.0707
2017-05-15 2017-03-31 13F Bristol Myers Squibb COM 110122108 6,286 18 0.29 342 -6.56 0.0691
2017-02-15 2016-12-31 13F Bristol Myers Squibb COM 110122108 6,268 -1,697 -21.31 366 -14.69 0.0822
2016-11-15 2016-09-30 13F Bristol Myers Squibb COM 110122108 7,965 0 0.00 429 -26.79 0.1629
2016-07-12 2016-06-30 13F Bristol Myers Squibb COM 110122108 7,965 0 0.00 586 15.13 0.2524
2016-05-13 2016-03-31 13F/A-1 Bristol Myers Squibb COM 110122108 7,965 -346 -4.16 509 -11.01 0.2565
2016-05-13 2016-03-31 13F Bristol Myers Squibb COM 110122108 7,965 509
2016-02-04 2015-12-31 13F Bristol Myers Squibb COM 110122108 8,311 -133 -1.58 572 14.40 0.3092
2015-11-04 2015-09-30 13F Bristol Myers Squibb COM 110122108 8,444 -291 -3.33 500 -14.38 0.2795
2015-07-31 2015-06-30 13F Bristol Myers Squibb COM 110122108 8,735 384 4.60 584 8.35 0.2784
2015-05-14 2015-03-31 13F Bristol Myers Squibb COM 110122108 8,351 8,351 539 0.2703
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.